BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarkar C, Mondal M, Torequl Islam M, Martorell M, Docea AO, Maroyi A, Sharifi-Rad J, Calina D. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives. Front Pharmacol 2020;11:572870. [PMID: 33041814 DOI: 10.3389/fphar.2020.572870] [Cited by in Crossref: 31] [Cited by in F6Publishing: 48] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Hossain R, Quispe C, Khan RA, Saikat ASM, Ray P, Ongalbek D, Yeskaliyeva B, Jain D, Smeriglio A, Trombetta D, Kiani R, Kobarfard F, Mojgani N, Saffarian P, Ayatollahi SA, Sarkar C, Islam MT, Keriman D, Uçar A, Martorell M, Sureda A, Pintus G, Butnariu M, Sharifi-Rad J, Cho WC. Propolis: An update on its chemistry and pharmacological applications. Chin Med 2022;17:100. [PMID: 36028892 DOI: 10.1186/s13020-022-00651-2] [Reference Citation Analysis]
2 Kaur I, Behl T, Sehgal A, Singh S, Sharma N, Subramanian V, Fuloria S, Fuloria NK, Sekar M, Dailah HG, Alsubayiel AM, Bhatia S, Al-Harrasi A, Aleya L, Bungau S. A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic. Environ Sci Pollut Res Int 2022. [PMID: 35933528 DOI: 10.1007/s11356-022-22345-w] [Reference Citation Analysis]
3 Castañeda-Juárez M, Linares-Hernández I, Martínez-Miranda V, Teutli-Sequeira EA, Castillo-Suárez LA, Sierra-Sánchez AG. SARS-CoV-2 pharmaceutical drugs: a critical review on the environmental impacts, chemical characteristics, and behavior of advanced oxidation processes in water. Environ Sci Pollut Res Int 2022. [PMID: 35930148 DOI: 10.1007/s11356-022-22234-2] [Reference Citation Analysis]
4 Sezer A, Halilović-Alihodžić M, Vanwieren AR, Smajkan A, Karić A, Djedović H, Šutković J. A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives. J Genet Eng Biotechnol 2022;20:78. [PMID: 35608704 DOI: 10.1186/s43141-022-00353-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Warsi T, Arora T, Rizvi SS, Moosvi AR, Aslam MAM, Khan MMA, Mohammed A. Novel Coronavirus (SARS-CoV-2) in Water and Environment—A Scoping Review. Life 2022;12:520. [DOI: 10.3390/life12040520] [Reference Citation Analysis]
6 Bahun M, Jukić M, Oblak D, Kranjc L, Bajc G, Butala M, Bozovičar K, Bratkovič T, Podlipnik Č, Poklar Ulrih N. Inhibition of the SARS-CoV-2 3CLpro main protease by plant polyphenols. Food Chem 2022;373:131594. [PMID: 34838409 DOI: 10.1016/j.foodchem.2021.131594] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
7 Akbari N, Ostadrahimi A, Tutunchi H, Pourmoradian S, Farrin N, najafipour F, Soleimanzadeh H, Kafil B, Mobasseri M. Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial. Journal of Trace Elements in Medicine and Biology 2022. [DOI: 10.1016/j.jtemb.2022.126945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jukič M, Kores K, Janežič D, Bren U. Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints. Front Chem 2021;9:757826. [PMID: 35028304 DOI: 10.3389/fchem.2021.757826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Huynh H, Levitz R, Huang R, Kahn JS. mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses. Sci Rep 2021;11:24442. [PMID: 34952911 DOI: 10.1038/s41598-021-03814-7] [Reference Citation Analysis]
10 Lak E, Mohammadi MJ, Yousefi H. Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients. Toxicol Rep 2022;9:46-52. [PMID: 34934636 DOI: 10.1016/j.toxrep.2021.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zou H, Yang Y, Dai H, Xiong Y, Wang JQ, Lin L, Chen ZS. Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment. Front Pharmacol 2021;12:732403. [PMID: 34880750 DOI: 10.3389/fphar.2021.732403] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Mukherjee T, Behl T, Sharma S, Sehgal A, Singh S, Sharma N, Mathew B, Kaur J, Kaur R, Das M, Aleya L, Bungau S. Anticipated pharmacological role of Aviptadil on COVID-19. Environ Sci Pollut Res Int 2021. [PMID: 34846667 DOI: 10.1007/s11356-021-17824-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Sharma P, Singh N, Sharma S. ATP binding cassette transporters and cancer: revisiting their controversial role. Pharmacogenomics 2021;22:1211-35. [PMID: 34783261 DOI: 10.2217/pgs-2021-0116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Papakonstantinou E, Dragoumani K, Efthimiadou A, Palaiogeorgou AM, Pierouli K, Mitsis T, Chrousos GP, Bacopoulou F, Vlachakis D. Haematological malignancies implications during the times of the COVID-19 pandemic. Oncol Lett 2021;22:856. [PMID: 34777590 DOI: 10.3892/ol.2021.13117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Fazeli A, Sharifi S, Mohammadi S, Bahraini M, Arabkhazaeli A, Jelveh N, Eshghi P. The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection. Transfus Apher Sci 2021;:103302. [PMID: 34774440 DOI: 10.1016/j.transci.2021.103302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kostoff RN, Calina D, Kanduc D, Briggs MB, Vlachoyiannopoulos P, Svistunov AA, Tsatsakis A. Why are we vaccinating children against COVID-19? Toxicol Rep 2021;8:1665-84. [PMID: 34540594 DOI: 10.1016/j.toxrep.2021.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tagde P, Tagde S, Tagde P, Bhattacharya T, Monzur SM, Rahman MH, Otrisal P, Behl T, Ul Hassan SS, Abdel-Daim MM, Aleya L, Bungau S. Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2. Biomedicines 2021;9:1266. [PMID: 34572452 DOI: 10.3390/biomedicines9091266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
19 Calina D, Hernández AF, Hartung T, Egorov AM, Izotov BN, Nikolouzakis TK, Tsatsakis A, Vlachoyiannopoulos PG, Docea AO. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2. Life (Basel) 2021;11:907. [PMID: 34575056 DOI: 10.3390/life11090907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sarkar C, Abdalla M, Mondal M, Khalipha ABR, Ali N. Ebselen suitably interacts with the potential SARS-CoV-2 targets: an in-silico approach. J Biomol Struct Dyn 2021;:1-16. [PMID: 34459720 DOI: 10.1080/07391102.2021.1971562] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Salaris C, Scarpa M, Elli M, Bertolini A, Guglielmetti S, Pregliasco F, Brun P, Castagliuolo I. Lacticaseibacillus paracasei DG enhances the lactoferrin anti-SARS-CoV-2 response in Caco-2 cells. Gut Microbes 2021;13:1961970. [PMID: 34365895 DOI: 10.1080/19490976.2021.1961970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
22 Li C, He Q, Qian H, Liu J. Overview of the pathogenesis of COVID-19 (Review). Exp Ther Med 2021;22:1011. [PMID: 34345293 DOI: 10.3892/etm.2021.10444] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Singh L, Bajaj S, Gadewar M, Verma N, Ansari MN, Saeedan AS, Kaithwas G, Singh M. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis. Front Immunol 2021;12:660632. [PMID: 34305892 DOI: 10.3389/fimmu.2021.660632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Schranz D. COVID-19 in children: acute endotheliopathy, but forgotten prostacyclin replacement? Cardiol Young 2021;:1-2. [PMID: 34227929 DOI: 10.1017/S1047951121002626] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Alam S, Sarker MMR, Afrin S, Richi FT, Zhao C, Zhou JR, Mohamed IN. Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions. Front Pharmacol 2021;12:671498. [PMID: 34122096 DOI: 10.3389/fphar.2021.671498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
26 Choudhury A, Mukherjee G, Mukherjee S. Chemotherapy vs. Immunotherapy in combating nCOVID19: An update. Hum Immunol 2021;82:649-58. [PMID: 34020832 DOI: 10.1016/j.humimm.2021.05.001] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
27 Wadaa-Allah A, Emhamed MS, Sadeq MA, Ben Hadj Dahman N, Ullah I, Farrag NS, Negida A. Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review. Ann Med 2021;53:318-34. [PMID: 33706639 DOI: 10.1080/07853890.2021.1875500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
28 Aghayari Sheikh Neshin S, Shahjouei S, Koza E, Friedenberg I, Khodadadi F, Sabra M, Kobeissy F, Ansari S, Tsivgoulis G, Li J, Abedi V, Wolk DM, Zand R. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front Cardiovasc Med 2021;8:649922. [PMID: 33855053 DOI: 10.3389/fcvm.2021.649922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kneller DW, Phillips G, Weiss KL, Zhang Q, Coates L, Kovalevsky A. Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography. J Med Chem 2021;64:4991-5000. [PMID: 33755450 DOI: 10.1021/acs.jmedchem.1c00058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
30 Pashaei Y. Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives? J Clin Neurosci 2021;88:163-72. [PMID: 33992179 DOI: 10.1016/j.jocn.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
31 Delshad M, Tavakolinia N, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Bagheri N, Bashash D. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int Immunopharmacol 2021;95:107586. [PMID: 33765611 DOI: 10.1016/j.intimp.2021.107586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
32 Attia YA, El-Saadony MT, Swelum AA, Qattan SYA, Al-Qurashi AD, Asiry KA, Shafi ME, Elbestawy AR, Gado AR, Khafaga AF, Hussein EOS, Ba-Awadh H, Tiwari R, Dhama K, Alhussaini B, Alyileili SR, El-Tarabily KA, Abd El-Hack ME. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review. Environ Sci Pollut Res Int 2021;28:22241-64. [PMID: 33733422 DOI: 10.1007/s11356-021-13018-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
33 Calina D, Hartung T, Mardare I, Mitroi M, Poulas K, Tsatsakis A, Rogoveanu I, Docea AO. COVID-19 pandemic and alcohol consumption: Impacts and interconnections. Toxicol Rep 2021;8:529-35. [PMID: 33723508 DOI: 10.1016/j.toxrep.2021.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
34 Pallotto C, Suardi LR, Gabbuti A, Esperti S, Mecocci L, Blanc P. Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19). J Med Virol 2021;93:2631-4. [PMID: 33620107 DOI: 10.1002/jmv.26898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
35 Liang SB, Zhang YY, Shen C, Liang CH, Lai BY, Dai N, Li YQ, Tian ZY, Zhang XW, Jiang Y, Xiong M, Zhang YP, Zhang Y, Robinson N, Liu JP. Chinese Herbal Medicine Used With or Without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies. Front Pharmacol 2020;11:583450. [PMID: 33716720 DOI: 10.3389/fphar.2020.583450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Scotto R, Pinchera B, Perna F, Atripaldi L, Giaccone A, Sequino D, Zappulo E, Sardanelli A, Schiano Moriello N, Stanziola A, Bocchino M, Gentile I, Sanduzzi A. Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia. Int J Environ Res Public Health 2021;18:2078. [PMID: 33672761 DOI: 10.3390/ijerph18042078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
37 Lora-Tamayo J, Maestro G, Lalueza A, Rubio-Rivas M, Villarreal Paul G, Arnalich Fernández F, Beato Pérez JL, Vargas Núñez JA, Llorente Barrio M, Lumbreras Bermejo C; SEMI-COVID-19 Network. Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study. J Infect 2021;82:276-316. [PMID: 33582204 DOI: 10.1016/j.jinf.2021.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
38 Islam MT, Quispe C, Martorell M, Docea AO, Salehi B, Calina D, Reiner Ž, Sharifi-rad J. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19. International Journal for Vitamin and Nutrition Research. [DOI: 10.1024/0300-9831/a000694] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
39 Bellera CL, Llanos M, Gantner ME, Rodriguez S, Gavernet L, Comini M, Talevi A. Can drug repurposing strategies be the solution to the COVID-19 crisis? Expert Opin Drug Discov 2021;16:605-12. [PMID: 33345645 DOI: 10.1080/17460441.2021.1863943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
40 Niu J, Chen H, Chen K, Liu Y, Ju F, Xue T, Yin D, Li C, Yin C, Jiao L, Zhao G, Huang J. Effect of pharmaceutical care on the treatment of COVID-19: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e23377. [PMID: 33235111 DOI: 10.1097/MD.0000000000023377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Farsalinos K, Poulas K, Kouretas D, Vantarakis A, Leotsinidis M, Kouvelas D, Docea AO, Kostoff R, Gerotziafas GT, Antoniou MN, Polosa R, Barbouni A, Yiakoumaki V, Giannouchos TV, Bagos PG, Lazopoulos G, Izotov BN, Tutelyan VA, Aschner M, Hartung T, Wallace HM, Carvalho F, Domingo JL, Tsatsakis A. Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare. Toxicol Rep 2021;8:1-9. [PMID: 33294384 DOI: 10.1016/j.toxrep.2020.12.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
42 Lopes N, Vernuccio F, Costantino C, Imburgia C, Gregoretti C, Salomone S, Drago F, Lo Bianco G. An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting. Front Public Health 2020;8:572042. [PMID: 33330317 DOI: 10.3389/fpubh.2020.572042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
43 Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19? J Pers Med 2020;10:E217. [PMID: 33182350 DOI: 10.3390/jpm10040217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
44 Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, Spandidos DA, Tsatsakis A. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep 2020;7:1448-58. [PMID: 33110761 DOI: 10.1016/j.toxrep.2020.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
45 Sharifi-Rad J, Kamiloglu S, Yeskaliyeva B, Beyatli A, Alfred MA, Salehi B, Calina D, Docea AO, Imran M, Anil Kumar NV, Romero-Román ME, Maroyi A, Martorell M. Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action. Front Pharmacol 2020;11:571459. [PMID: 33192514 DOI: 10.3389/fphar.2020.571459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
46 Malekzadeh R, Abedini A, Mohsenpour B, Sharifipour E, Ghasemian R, Javad-Mousavi SA, Khodashahi R, Darban M, Kalantari S, Abdollahi N, Salehi MR, Rezaei Hosseinabadi A, Khorvash F, Valizadeh M, Dastan F, Yousefian S, Hosseini H, Anjidani N, Tabarsi P. Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol 2020;89:107102. [PMID: 33075713 DOI: 10.1016/j.intimp.2020.107102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
47 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 40.0] [Reference Citation Analysis]
48 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Reference Citation Analysis]